Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):571-9. doi: 10.1089/cap.2011.0057. Epub 2011 Dec 13.

2.

Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders.

Murray MJ.

Curr Psychiatry Rep. 2010 Oct;12(5):382-8. doi: 10.1007/s11920-010-0145-3. Review.

PMID:
20694583
3.

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

Mahajan R, Bernal MP, Panzer R, Whitaker A, Roberts W, Handen B, Hardan A, Anagnostou E, Veenstra-VanderWeele J; Autism Speaks Autism Treatment Network Psychopharmacology Committee..

Pediatrics. 2012 Nov;130 Suppl 2:S125-38. doi: 10.1542/peds.2012-0900J. Review.

4.

[Autism and attention deficit hyperactivity disorder: pharmacological intervention].

Fernández-Jaén A, Martín Fernández-Mayoralas D, Fernández-Perrone AL, Calleja-Pérez B, Muñoz-Jareño N, López-Arribas S.

Rev Neurol. 2013 Sep 6;57 Suppl 1:S205-10. Review. Spanish.

5.

Psychopharmacological interventions in autism spectrum disorder.

Accordino RE, Kidd C, Politte LC, Henry CA, McDougle CJ.

Expert Opin Pharmacother. 2016;17(7):937-52. doi: 10.1517/14656566.2016.1154536. Epub 2016 Mar 7. Review.

PMID:
26891879
6.

Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.

Davis NO, Kollins SH.

Neurotherapeutics. 2012 Jul;9(3):518-30. doi: 10.1007/s13311-012-0126-9. Review.

7.

Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder.

Handen BL, Taylor J, Tumuluru R.

Int J Adolesc Med Health. 2011;23(3):167-73. Review.

PMID:
22191179
8.

Psychopharmacological interventions in autism spectrum disorder.

Politte LC, Henry CA, McDougle CJ.

Harv Rev Psychiatry. 2014 Mar-Apr;22(2):76-92. doi: 10.1097/HRP.0000000000000030. Review.

PMID:
24614763
9.

Autism spectrum disorders, attention deficit/hyperactivity disorder, and sleep disorders.

Ming X, Walters AS.

Curr Opin Pulm Med. 2009 Nov;15(6):578-84. doi: 10.1097/MCP.0b013e3283319a9a. Review.

PMID:
19713848
10.
11.

Diagnosing attention-deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations?

Klein B, Damiani-Taraba G, Koster A, Campbell J, Scholz C.

Child Care Health Dev. 2015 Mar;41(2):178-85. doi: 10.1111/cch.12168. Epub 2014 Jun 18. Review.

PMID:
24942100
13.

[Psychopharmacology of autism spectrum disorders].

Poustka L, Banaschewski T, Poustka F.

Nervenarzt. 2011 May;82(5):582-9. doi: 10.1007/s00115-010-3238-7. Review. German.

PMID:
21484169
14.

Pharmacotherapy of autism spectrum disorders.

Benvenuto A, Battan B, Porfirio MC, Curatolo P.

Brain Dev. 2013 Feb;35(2):119-27. doi: 10.1016/j.braindev.2012.03.015. Epub 2012 Apr 25. Review.

PMID:
22541665
15.

Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.

Jobski K, Höfer J, Hoffmann F, Bachmann C.

Acta Psychiatr Scand. 2017 Jan;135(1):8-28. doi: 10.1111/acps.12644. Epub 2016 Sep 13. Review.

PMID:
27624381
16.

Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment.

Reiersen AM, Todd RD.

Expert Rev Neurother. 2008 Apr;8(4):657-69. doi: 10.1586/14737175.8.4.657. Review.

PMID:
18416666
17.
18.

A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder.

Craig F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L.

Neuropsychiatr Dis Treat. 2016 May 12;12:1191-202. doi: 10.2147/NDT.S104620. eCollection 2016 May 12. Review.

19.

Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date.

Potter AS, Schaubhut G, Shipman M.

CNS Drugs. 2014 Dec;28(12):1103-13. doi: 10.1007/s40263-014-0208-9. Review.

20.

Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years?

Miller TW, Nigg JT, Miller RL.

Clin Psychol Rev. 2009 Feb;29(1):77-86. doi: 10.1016/j.cpr.2008.10.001. Epub 2008 Oct 11. Review.

Supplemental Content

Support Center